Medical Director BBU & RD

At AstraZeneca , we are a science-led, patient-focused biopharmaceutical company committed to pushing the boundaries of science to deliver life-changing medicines. We work across multiple therapeutic areas and combine scientific expertise, innovation, collaboration, and technology to address some of the world’s most complex healthcare challenges. Joining AstraZeneca means becoming part of a diverse and inclusive organization where people are empowered to bring their ideas, expertise, and perspectives to work. We offer the opportunity to contribute to meaningful outcomes for patients while working in an environment that encourages curiosity, continuous learning, courageous leadership, and collaboration across countries, functions, and cultures. About the role The Medical Director, Biopharmaceuticals Business Unit (BBU) & Rare Disease (RD) South Cone, is accountable for leading the country medical strategy and execution across prioritized BBU therapeutic areas (e.g., cardiovascular, renal & metabolism, respiratory, vaccines & immune therapies, and rare diseases). The role ensures scientific leadership, evidence generation, data dissemination, and compliant medical engagement that advance patient outcomes, inform clinical practice, and support sustainable business performance. Key responsibilities • Medical strategy and leadership : Own the end‑to‑end BBU country medical plan aligned with global/region priorities and local patient needs. Set clear objectives, KPIs, and risk controls for brand and portfolio medical activities. • Therapeutic area (TA) excellence : Serve as the senior scientific authority for assigned TAs, ensuring up‑to‑date understanding of disease biology, evolving standards of care, competitive landscape, and local guidelines in the region. • Evidence generation : Lead local evidence plans including IIS/IST support, RWE/HEOR projects, non‑interventional studies, and post‑authorization commitments in accordance with regulations and SOPs. Partner with Clinical Operations on feasibility, site identification, and patient access initiatives. • External engagement : Build and sustain strategic, compliant relationships with scientific leaders, professional societies, academic centers, and patient organizations. Represent the company at national congresses and advisory boards; orchestrate high‑quality scientific exchange. • Medical governance and compliance : Ensure all medical activities comply with local regulations, industry codes, and company policies (approval, review, and documentation). Chair or contribute to medical review committees for promotional and non‑promotional materials. • Insight generation : Systematically collect, synthesize, and communicate medical insights to shape strategy, lifecycle management, forecasting, and market access value propositions. • Publications and data communication : Drive publication plans, data clarity, and consistent scientific narratives across channels. Ensure timely, accurate, and balanced medical information responses. • Cross‑functional partnership : Co‑lead with Commercial, Market Access, Government Affairs, and Patient Safety to deliver integrated brand plans, payer value stories, and risk‑minimization activities. Act as the medical voice in pricing/HTA submissions, tenders, and access negotiations as appropriate. • Medical education : Oversee the design and delivery of independent and company‑sponsored medical education aligned to unmet needs and evidence, ensuring speaker training and content quality. • Field medical leadership : Lead, coach, and develop MSL managers/MSLs; prioritize customer plans, scientific projects, and metrics (e.g., scientific exchange quality, KOL coverage, insight depth). • People and capability development : Recruit, mentor, and perfor